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Basic science, evidence, and clinical judgementKnowledge resulting from basic research may lead to
clinical research and subsequent practical application. But
it also happens that clinical observation and experience
evoke research that confirms previous judgement. In addi-
tion, evidence of effectivenes has been produced without
any plausible pathophysiological explanation yet available.
In other words, it seems that there are no standard recipes in
how effective clinical practice is being scientifically pre-
pared and realized. But, whatever route is followed, patho-
physiological insights, evidence for effectiveness, and
clinical judgement are coherenty contributing to the best
care for individual patients [1e3].
The complex and sometimes cumbersome relation be-
tween basic science, observational studies, and RCT-
based evidence is addressed in a commentary by Prasad
and Ho. They critically discuss the translation of preclinical
findings to medical practice, and also make suggestions to
promote all available previous research findings being ap-
propriately used and reviewed when evaluating the added
value of new studies. By the same token, systematic re-
views representing the available clinical evidence must be
as useful as possible, and topics nominated for reviews
should therefore be well-refined and focused on relevant
questions. For this purpose, based on the experience from
the Agency for Healthcare Research and Quality (AHRQ)
effective Health Care Program, Buckley et al. developed
a comprehensive set of guiding principles and methodolog-
ical recommendations that may help investigators refine
topics for reviews. A broad range of elements, from the
state of science to responsiveness to stakeholder inputs,
are among the criteria and principles to be used. The au-
thors expect that the methods in this field will continue to
evolve.
Optimally and efficiently contributing to an appropriate
picture of available evidence requires that overlap in pri-
mary studies in overviews (reviews of reviews) is well ad-
dressed. However, according to Pieper and his group, the
degree of such overlap has not been examined systemati-
cally. In a systematic review of overviews, these authors
show that overlaps are often not mentioned. They propose
the CCA (corrected covered area) method to comprehen-
sively report overlaps. Another relevant observation as to
the quality of synthesis of evidence is reported by Achana
and coworkers. In a systematic review of National Institute
for Health Care Excellence (NICE) public health apprais-
als, they found that quantitative synthesis is not carried0895-4356  2014 Elsevier Inc.
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Open access under CC BY-NC-ND license.out in systematic reviews for most public health evalua-
tions. And when it is done, often the simplest methods
are used, while more sophisticated methods are availabe
to make the evaluations more useful for decision makers.
The authors suggest that researchers working on public
health evaluations should expand their toolbox.
According to Kim et al., a serious limitation in develop-
ing the evidence base to make the best clinical decisions is
that comparisons between interventions for a certain health
problem are often made within a certain class of interven-
tions (e.g., pharmaceutical or surgical) or settings. How-
ever, for optimizing clinical practice, it is often necessary
to make comparisons across different types of interven-
tions. In a review of treatments for basal cell carcinoma,
these authors for the first time applied a network geometry
to address this issue and found that many important com-
parisons have still not been made. This finding has impor-
tant implications for future trial comparisons.
In the triad of basic science, evidence, and judgement, the
latter e while being relevant in each consultation - has been
much less investigated than the other two. This concerns both
the process of individual judgement and consensus proce-
dures. Therefore, the study by Diamond and colleagues is
welcomed. In a systematic review, they investigated how
consensus is defined and operationalized in Delphi studies,
and highlight the role of consensus in those studies. The au-
thors conclude that definitions of consensus vary consider-
ably, and propose methodologic criteria for the reporting of
Delphi studies.
Optimal translation from research to practice also im-
plies requirements for data analysis and presentation. In an-
alyzing a trial, it is important that demonstrated effects are
summarized and reported appropriately. In a commentary,
Furuya- Kanamori and Doi evaluate the pros and cons of
using relative risk and the odds ratio, and the role of the
baseline risk. The importance of the baseline situation is
also addressed by Rouquette and her team: using data from
a large cohort of hospitalized patients, their study demon-
strates that the minimally clinically important difference
(MCID) defined as a function of a range of baseline scores
leads to a better classification than the MCID without con-
sidering baseline severity. Furthermore, a classic challenge
in the analysis of trials is how to deal with subgroup anal-
ysis. As results of statistical testing of subgroup analyses
can be different when relative or absolute effect measures
are used, Venekamp and coworkers systematically reviewed
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found that, almost always, relative effect measures were
used. The authors advise that the CONSORT statement
should recommend the reporting of both relative and abso-
lute reduction for subgroup analyses. Another field where
more methodological guidance is suggested is the predic-
tion of chronic disease evolution from a prognostic marker.
Dantan et al. propose the use of simple equations to assess
time-dependent sensitivity, specificity, predictive values,
likelihood ratios, and posttest probability ratios, which
can help readers to better evaluate research articles report-
ing on prognostic markers. Their approach is illustrated us-
ing data from reported prognostic studies on kidney
transplantation and breast cancer.
Although for diagnostic accuracy research the develop-
ment of methodological criteria is much younger than for
randomized trials, standards for reporting primary studies
and reviews have been available now for a number of years.
This enabled Henschke c.s. to provide a literature review of
all systematic reviews of diagnostic test accuracy studies in
the musculoskelal field. They found much room for im-
provement of primary studies, and positively evaluated
the validity and consistency of the QUADAS checklist for
the accuracy of diagnostic accuracy studies.
Medical decisions in the field of clinical diagnosis are
often related to optimal thresholds. In a simulation study,
Hirschfeld and colleagues evaluated the performance of
empirically defined thresholds in various samples. They
found that optimal thresholds for tests that are known to re-
sult in medium to large differences, at the population level
still result in many misclassifications. Researchers must
therefore be careful in defining such cut points, and optimal
thresholds should be validated in prospective studies before
recommending them for clinical use.
There has been substantial methodological debate on the
stepped-wedge design, and opinions and experiences differ
[4]. Zhan et al. report on the advantages and disadvantages
of this design type, based on their experience with a trial
on detecting curable recurrences during follow-up after col-
orectal cancer. They conclude that the design is a strong
alternative for pragmatic cluster randomized trials, but diffi-
culties are the timing of the informed consent procedure and
the complexity of the data analysis.
Self-reported health is an important source of informa-
tion, but opportunities to compare this with objective meas-
urements are scarce. In an excercise program for sedentary
women, Gademan and her group were able to compare self-
reported physical activity with VO2max. No significant as-
sociation was found, and therefore, according to the authors,
physical activity and VO2max represent different aspects of
health in this group and cannot be used interchangeably.
Cabrero-Garcıa and co-authors used self-rated health
(SRH) as a reference to evaluate the Global Activity Limi-
tation Index (GALI) in the context of a national surveyamong elderly people. It was found that, whereas the GALI
mainly measured functional disability, SRH mainly meas-
ured physical morbidity.
In striving for more efficient collection of evidence, it is
often assumed that reducing questionnaire length would im-
prove response rate in surveys among physicians. This was
not confirmed in a randomized trial of Bolt et al., comparing
the responses to a long and short version of a questionnaire
on end-of-life decisions. But sending a a drastically short-
ened questionnaire version to non-responders did improve
the response rate. Another method to increase physician sur-
vey response, a charitable donation incentive, was tested by
Nesrallah c.s. in a randomized trial. In their letter the au-
thors report no effect, and given the growing demand on
physicians time they make a plea for better strategies.Many thanks to Martin Prins, welcome to John
Ioannidis
After many years of service to the Journal, professor
Martin Prins, professor of Clinical Epidemiology at Maas-
tricht University, has retired from his post of associate edi-
tor. We have highly appreciated his contributions to further
developing the journal and his excellent inputs at our
annual editorial retreats. At the same time, we are delighted
to welcome professor John Ioannidis as new associate edi-
tor. He is professor of Medicine and director of the Stanford
Prevention Research Center at Stanford University School
of Medicine (USA), holding also various other positions
at that university, and professor and chairman at the Depart-
ment of Hygiene and Epidemiology, University of Ioannina
School of Medicine, Greece. He is one of the world’s most
creative and productive medical and epidemiological re-
searchers. We are happy that John joins the core team of
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